James Sidoti
Stock Analyst at Sidoti & Co.
(3.02)
# 1,454
Out of 5,090 analysts
8
Total ratings
60%
Success rate
71.66%
Average return
Main Sectors:
Stocks Rated by James Sidoti
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STAA STAAR Surgical Company | Downgrades: Neutral | $27 → $28 | $25.38 | +10.32% | 3 | Aug 5, 2025 | |
| CODX Co-Diagnostics | Downgrades: Neutral | $5 | $0.37 | +1,235.11% | 1 | Aug 12, 2022 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $38 → $34 | $84.53 | -59.78% | 2 | Apr 8, 2020 | |
| ANIK Anika Therapeutics | Upgrades: Buy | $61 | $9.60 | +535.42% | 2 | Jan 21, 2020 |
STAAR Surgical Company
Aug 5, 2025
Downgrades: Neutral
Price Target: $27 → $28
Current: $25.38
Upside: +10.32%
Co-Diagnostics
Aug 12, 2022
Downgrades: Neutral
Price Target: $5
Current: $0.37
Upside: +1,235.11%
LeMaitre Vascular
Apr 8, 2020
Maintains: Buy
Price Target: $38 → $34
Current: $84.53
Upside: -59.78%
Anika Therapeutics
Jan 21, 2020
Upgrades: Buy
Price Target: $61
Current: $9.60
Upside: +535.42%